Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum microRNA-122 predicts survival in patients with liver cirrhosis.
Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B. Waidmann O, et al. Among authors: kronenberger b. PLoS One. 2012;7(9):e45652. doi: 10.1371/journal.pone.0045652. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029162 Free PMC article.
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A. Bihrer V, et al. Among authors: kronenberger b. Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24. Am J Gastroenterol. 2011. PMID: 21606975 Free article.
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, Welker M, Shi Y, Peveling-Oberhag J, Polta A, von Wagner M, Radeke HH, Sarrazin C, Trojan J, Zeuzem S, Kronenberger B, Piiper A. Bihrer V, et al. Among authors: kronenberger b. PLoS One. 2011;6(10):e26971. doi: 10.1371/journal.pone.0026971. Epub 2011 Oct 31. PLoS One. 2011. PMID: 22066022 Free PMC article.
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Schmithals C, Köberle V, Korkusuz H, Pleli T, Kakoschky B, Augusto EA, Ibrahim AA, Arencibia JM, Vafaizadeh V, Groner B, Korf HW, Kronenberger B, Zeuzem S, Vogl TJ, Waidmann O, Piiper A. Schmithals C, et al. Among authors: kronenberger b. Cancer Res. 2015 Aug 1;75(15):3147-54. doi: 10.1158/0008-5472.CAN-15-0395. Cancer Res. 2015. PMID: 26239478
99 results